Sarah Spiegel

Title: Sarah Spiegel: Innovator in Sphingosine Kinase Research

Introduction

Sarah Spiegel is a prominent inventor based in McLean, VA (US). She has made significant contributions to the field of biochemistry, particularly in the study of sphingosine kinases. With a total of 8 patents to her name, her work has advanced our understanding of these important enzymes.

Latest Patents

Among her latest patents is an invention titled "Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof." This patent focuses on the development of polyclonal or monoclonal antibodies that are specific for a mammalian sphingosine kinase type 2 isoform protein. These antibodies are crucial for detecting the presence of sphingosine kinase type 2 isoform. Another notable patent is "Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof." This invention includes nucleic acids encoding mouse and human sphingosine kinase type 2 isoforms, along with methods for detecting agents or drugs that inhibit or promote sphingosine activity.

Career Highlights

Throughout her career, Sarah has worked with various institutions, including Georgetown University. Her research has been instrumental in the development of therapeutic agents that contain peptides or antibodies encoded by the nucleic acids she has studied.

Collaborations

Sarah has collaborated with notable colleagues such as Takafumi Kohama and Naishadh N Desai. Their combined expertise has furthered the research in sphingosine kinase and its applications.

Conclusion

In summary, Sarah Spiegel is a distinguished inventor whose work in sphingosine kinase research has led to significant advancements in the field. Her contributions continue to impact biochemistry and therapeutic development.